# Oncobiologics, Inc.

Type: Company (OTLK)

Source: Finance Intelligence Brief — https://getfinancebrief.com/entity/oncobiologics-inc
Canonical HTML page: https://getfinancebrief.com/entity/oncobiologics-inc

## Recent coverage (1 stories)

### OTLK Shares -14.6% on 104M Volume After $0.01 EPS Miss
2026-08-16 18:20:39 · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Finance and markets: Oncobiologics missed EPS by $0.01 and reported $0.01M revenue, yet 104M shares traded (6x volume) as insiders bought $5.16M; Galectin missed by $0.05.
Full story: https://getfinancebrief.com/story/otlk-galt-earnings-miss-finance-volume

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getfinancebrief.com/guides/methodology for the full editorial methodology.